Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 786

1.

Graft-versus-host disease causes failure of donor hematopoiesis and lymphopoiesis in interferon-gamma receptor-deficient hosts.

Delisle JS, Gaboury L, Bélanger MP, Tassé E, Yagita H, Perreault C.

Blood. 2008 Sep 1;112(5):2111-9. doi: 10.1182/blood-2007-12-130534. Epub 2008 Jun 13.

PMID:
18552211
[PubMed - indexed for MEDLINE]
Free Article
2.

IFN-gamma and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease.

Ramirez-Montagut T, Chow A, Kochman AA, Smith OM, Suh D, Sindhi H, Lu S, Borsotti C, Grubin J, Patel N, Terwey TH, Kim TD, Heller G, Murphy GF, Liu C, Alpdogan O, van den Brink MR.

J Immunol. 2007 Aug 1;179(3):1669-80.

PMID:
17641033
[PubMed - indexed for MEDLINE]
Free Article
3.

Fas-deficient lpr mice are more susceptible to graft-versus-host disease.

van Den Brink MR, Moore E, Horndasch KJ, Crawford JM, Hoffman J, Murphy GF, Burakoff SJ.

J Immunol. 2000 Jan 1;164(1):469-80.

PMID:
10605044
[PubMed - indexed for MEDLINE]
Free Article
4.

Separation of antileukemic effects from graft-versus-host disease in MHC-haploidentical murine bone marrow transplantation: participation of host immune cells.

Satake A, Inoue T, Kubo S, Taniguchi Y, Imado T, Fujioka T, Horiuchi M, Xu Y, Ikegame K, Yoshihara S, Kaida K, Tamaki H, Okada M, Okamura H, Ogawa H.

Int J Hematol. 2010 Apr;91(3):485-97. doi: 10.1007/s12185-010-0545-5. Epub 2010 Mar 20.

PMID:
20300982
[PubMed - indexed for MEDLINE]
5.

Donor-derived interferon gamma separates graft-versus-leukemia effects and graft-versus-host disease induced by donor CD8 T cells.

Yang YG, Qi J, Wang MG, Sykes M.

Blood. 2002 Jun 1;99(11):4207-15.

PMID:
12010827
[PubMed - indexed for MEDLINE]
Free Article
6.

Donor T cells lacking Fas ligand and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipients.

Marks L, Altman NH, Podack ER, Levy RB.

Transplantation. 2004 Mar 27;77(6):804-12.

PMID:
15077018
[PubMed - indexed for MEDLINE]
7.
8.

Opposing roles of interferon-gamma on CD4+ T cell-mediated graft-versus-host disease: effects of conditioning.

Welniak LA, Blazar BR, Anver MR, Wiltrout RH, Murphy WJ.

Biol Blood Marrow Transplant. 2000;6(6):604-12.

PMID:
11128810
[PubMed - indexed for MEDLINE]
9.

Paradoxical effects of IFN-gamma in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury.

Wang H, Asavaroengchai W, Yeap BY, Wang MG, Wang S, Sykes M, Yang YG.

Blood. 2009 Apr 9;113(15):3612-9. doi: 10.1182/blood-2008-07-168419. Epub 2009 Feb 10.

PMID:
19211507
[PubMed - indexed for MEDLINE]
Free PMC Article
10.
12.

Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions.

Blazar BR, Lees CJ, Martin PJ, Noelle RJ, Kwon B, Murphy W, Taylor PA.

J Immunol. 2000 Nov 1;165(9):4901-9.

PMID:
11046015
[PubMed - indexed for MEDLINE]
Free Article
13.

Bone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect.

Capitini CM, Herby S, Milliron M, Anver MR, Mackall CL, Fry TJ.

Blood. 2009 May 14;113(20):5002-9. doi: 10.1182/blood-2008-11-187385. Epub 2009 Mar 3.

PMID:
19258593
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice.

Yang YG, Sergio JJ, Pearson DA, Szot GL, Shimizu A, Sykes M.

Blood. 1997 Dec 1;90(11):4651-60.

PMID:
9373279
[PubMed - indexed for MEDLINE]
Free Article
15.

Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12.

Yang YG, Dey BR, Sergio JJ, Pearson DA, Sykes M.

J Clin Invest. 1998 Dec 15;102(12):2126-35.

PMID:
9854048
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.

Murphy WJ, Welniak LA, Taub DD, Wiltrout RH, Taylor PA, Vallera DA, Kopf M, Young H, Longo DL, Blazar BR.

J Clin Invest. 1998 Nov 1;102(9):1742-8.

PMID:
9802888
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.

Jones MS, Riley R, Hamilton BL, Paupe J, Perez D, Levy RB.

Bone Marrow Transplant. 1994 Nov;14(5):725-35.

PMID:
7889005
[PubMed - indexed for MEDLINE]
18.

An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease.

Welniak LA, Wang Z, Sun K, Kuziel W, Anver MR, Blazar BR, Murphy WJ.

Exp Hematol. 2004 Mar;32(3):318-24.

PMID:
15003318
[PubMed - indexed for MEDLINE]
19.

Regulatory role of host CD8+ T lymphocytes in experimental graft-versus-host disease across a single major histocompatibility complex class II incompatibility.

de Lavareille A, Prigogine C, Paulart F, Nagy N, Habran C, Haddou NO, Le Moine A, Salmon I, Goldman M, Flamand V.

Transplantation. 2005 Nov 15;80(9):1293-9.

PMID:
16314798
[PubMed - indexed for MEDLINE]
20.

Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease.

Maeda Y, Levy RB, Reddy P, Liu C, Clouthier SG, Teshima T, Ferrara JL.

Blood. 2005 Mar 1;105(5):2023-7. Epub 2004 Oct 5.

PMID:
15466930
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk